about
Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradationLicensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHTAngiopoietin-2 is critical for cytokine-induced vascular leakageVEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?Measurement of Angiogenesis, Arteriolargenesis, and Lymphangiogenesis Phenotypes by Use of Two-Dimensional Mesenteric Angiogenesis Assay.Measurement of angiogenic phenotype by use of two-dimensional mesenteric angiogenesis assayThe Orphan Receptor Tie1 Controls Angiogenesis and Vascular Remodeling by Differentially Regulating Tie2 in Tip and Stalk Cells.Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature.BDNF (Brain-Derived Neurotrophic Factor) Promotes Embryonic Stem Cells Differentiation to Endothelial Cells Via a Molecular Pathway, Including MicroRNA-214, EZH2 (Enhancer of Zeste Homolog 2), and eNOS (Endothelial Nitric Oxide Synthase)Physiological Role of Vascular Endothelial Growth Factors as Homeostatic RegulatorsVEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritisTension in the vasculatureVascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugsActivation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathwayEnhanced notch signaling modulates unproductive revascularization in response to nitric oxide-angiopoietin signaling in a mouse model of peripheral ischemia
P50
Q30495730-77276DFF-96C3-48F7-B230-4E49EFA9541CQ34831085-263B7585-E683-4E6D-90E3-F9AA8BF23E22Q34935131-16A3BD6D-C9BC-41BF-B5FE-1E447A278DABQ37035753-7F062F88-1E69-48EF-84F1-7B3921732F02Q37286610-B928B24E-748A-4248-9266-8433A8C5FB54Q39248182-3E26D383-AC95-44DA-96A4-F3CD0D8BB995Q39379527-2FEC3A3B-B6C7-4BBF-940C-7BBF4BFC6D8EQ39771379-9A38D201-D546-4DB8-A215-EBC3AC31C848Q39870434-D84E5E5C-A440-4F4A-AA95-588B10ED7CA9Q40567745-7E799BB3-6417-4B98-B540-2A553A4C7203Q40640090-1BD13AAE-CE7B-419A-9900-6858D1BE0798Q42266376-0191AF45-5944-442F-8561-A584B3E36FD8Q57822568-74174281-9D57-409A-8E4D-0C29DD0F7129Q57916044-6AE5AD85-0BC8-495F-8B58-50F4C6C02C13Q60061929-51129A39-FDF6-4856-A152-9CF98E2D3F1AQ61773841-7DF71BB8-3DF5-42E9-B65E-C39C6B76E1E3Q64377136-0F58FEB1-B336-4CBB-AFC9-960D1F980E38Q91218698-406ADDB7-CF47-4B6C-AC66-5116248BBF59Q93030769-5C9DEDF8-B87F-4280-9F89-B8312992DC61
P50
description
researcher
@en
wetenschapper
@nl
name
Andrew V Benest
@en
Andrew V Benest
@nl
type
label
Andrew V Benest
@en
Andrew V Benest
@nl
prefLabel
Andrew V Benest
@en
Andrew V Benest
@nl
P106
P31
P496
0000-0002-8225-5159